LETROZOLE

LETROZOLE

Introduction

Letrozole is a medication commonly used in the treatment of hormone-sensitive breast cancer, particularly in postmenopausal women. It belongs to a class of drugs known as aromatase inhibitors, which play a crucial role in managing estrogen-dependent cancers. This essay provides a detailed overview of letrozole, including its forms, uses, mechanisms, and considerations for safe use.

What is Letrozole?

Letrozole is a non-steroidal aromatase inhibitor that works by blocking the aromatase enzyme, which is responsible for converting androgens into estrogens in the body. By inhibiting this conversion, letrozole effectively lowers estrogen levels, which is beneficial in treating cancers that are driven by estrogen.

Dosage Forms and Strengths

Letrozole is available in oral tablet form, which is the primary mode of administration. The common strengths are:

  • Letrozole 2.5 mg: The standard and most frequently prescribed dose for the management of breast cancer.

Brand and Generic Names

Letrozole is marketed under several brand names, including:

  • Femara: The most well-known brand name for letrozole.
  • Generic Letrozole: Available as a generic drug, providing the same therapeutic effects at potentially lower costs.

Indications for Use

Letrozole is primarily used in the treatment of hormone-sensitive breast cancer. Its main indications include:

  1. Early-Stage Breast Cancer: Adjuvant treatment for postmenopausal women with early-stage hormone receptor-positive breast cancer.
  2. Advanced or Metastatic Breast Cancer: Treatment for postmenopausal women with hormone receptor-positive breast cancer that has spread to other parts of the body.
  3. Fertility Treatment: Off-label use in certain cases to induce ovulation in women with infertility issues, though this is less common.

Mechanism of Action

Letrozole’s primary action is the inhibition of the aromatase enzyme. Aromatase converts androgens (like testosterone and androstenedione) into estrogens (like estradiol and estrone). By blocking this enzyme, letrozole decreases estrogen levels in the body, thereby reducing the growth of estrogen-dependent tumors. This mechanism is particularly effective in postmenopausal women, who primarily produce estrogen through this pathway.

Administration and Dosage

The typical dosage for letrozole is:

  • Standard Dose: 2.5 mg once daily, taken orally.
  • Duration of Treatment: Treatment duration can vary based on the specific cancer type and stage, but it often lasts for several years, especially as part of adjuvant therapy.

Letrozole tablets should be taken with or without food, and patients should follow their healthcare provider’s instructions regarding dosage and duration.

Side Effects and Precautions

Letrozole is generally well-tolerated, but like all medications, it can cause side effects. Common and notable side effects include:

  • Hot Flashes: A frequent symptom due to lowered estrogen levels.
  • Joint and Muscle Pain: Discomfort in joints and muscles may occur.
  • Bone Density Loss: Long-term use can lead to decreased bone density, increasing the risk of osteoporosis and fractures.
  • Fatigue: Some patients may experience general fatigue.
  • Nausea and Vomiting: Gastrointestinal symptoms are possible.

Precautions to consider include:

  • Bone Health Monitoring: Regular bone density checks may be required for long-term users.
  • Interaction with Other Medications: Letrozole can interact with other drugs, including certain hormone therapies and medications affecting liver enzymes.
  • Pregnancy: Letrozole is contraindicated during pregnancy due to potential harm to the fetus.

Conclusion

Letrozole is a vital medication in the treatment of estrogen-dependent breast cancer, offering significant benefits by lowering estrogen levels through aromatase inhibition. Its efficacy in managing early-stage and advanced breast cancer makes it a cornerstone in oncological therapy for postmenopausal women. While generally well-tolerated, the potential side effects, especially related to bone health and joint pain, underscore the need for careful monitoring and medical supervision. Overall, letrozole’s role in cancer treatment demonstrates its importance in the ongoing fight against hormone-sensitive cancers.

Sort By:  
LETROZOLE 2.5 MG 50 TABLETS 1 UNITS MONO - FEMARA BELIGAS PHARMACEUTICALS (excluded of 20 USD Postage fee/order)
used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
93.00 USD
LETROZOLE 2.5 MG TAB 1 UNITS FEMARA BLACK DRAGON (excluded of 20 USD Postage fee/order)
used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
75.00 USD
75.00 USD
LETROZOLE 2.5 MG. 30 TAB 1 UNITS FEMARA BODYTECH (excluded of 20 USD Postage fee/order)
used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
59.00 USD
LETROZOLE TAB 2.5 MG 30 UNITS LETROMINA ALPHA PHARMA (excluded of 20 USD Postage fee/order)
used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
56.00 USD
LETROZOLE TAB 2.5 MG 50 UNITS FEMAMED 2.5 DEUS MEDICAL (excluded of 20 USD Postage fee/order)
used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
90.00 USD
LETROZOLE TAB 2.5 MG 50 UNITS FEMARA MEDITECH (excluded of 20 USD Postage fee/order)
used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
51.00 USD

LETROZOLE 2.5 MG 50 TABLETS 1 UNITS MONO - FEMARA BELIGAS PHARMACEUTICALS (excluded of 20 USD Postage fee/order) (MONO - FEMARA)

used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
93.00 USD
SALE

LETROZOLE 2.5 MG TAB 1 UNITS FEMARA BLACK DRAGON (excluded of 20 USD Postage fee/order) (FEMARA)

used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
75.00 USD
75.00 USD

LETROZOLE 2.5 MG. 30 TAB 1 UNITS FEMARA BODYTECH (excluded of 20 USD Postage fee/order) (FEMARA)

used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
59.00 USD

LETROZOLE TAB 2.5 MG 30 UNITS LETROMINA ALPHA PHARMA (excluded of 20 USD Postage fee/order) (LETROMINA)

used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
56.00 USD

LETROZOLE TAB 2.5 MG 50 UNITS FEMAMED 2.5 DEUS MEDICAL (excluded of 20 USD Postage fee/order) (FEMAMED 2.5)

used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
90.00 USD

LETROZOLE TAB 2.5 MG 50 UNITS FEMARA MEDITECH (excluded of 20 USD Postage fee/order) (FEMARA)

used in the treatment of hormonally responsive breast cancer, particularly in postmenopausal women
51.00 USD

GTM

Jinimed © 2024Powered By  AbanteCart